NOTES FROM
THE PHARMACEUTICAL INDUSTRY


According to free-market and overall tender data of IQVIA*, 2,548 million boxes and TL 43.8 billion (*) worth of medicines were sold in Turkish pharmaceutical market in 2019. The market achieved growth at a rate of 2.7% in number of units and at a rate of 31.4% in TL compared with the previous year.

Rate of prescription drugs to the total pharmaceutical market in Turkish market is 96.8% in number of unitsand 95.2% in TL.

Although drugs from many treatment groups are imported in our country, preparations requiring new and advanced technology, anti-cancer medicines, blood factors, nervous system drugs, insulin, and some controlled-release drugs are predominantly imported.

According to IQVIA data, the sector’s import decreased by 4.2% on a box basis and increased by 5.4% on USD basis, resulting in USD 3.9 billion in 2019. The domestic pharmaceutical market grew by 4.3% on a box basis and grew by about 13.5% on USD basis, resulting in USD 3,8 billion. The rate of import to the total market was 17.6% on a box basis and 50.6% on USD basis.

According to IQVIA data, the sector grew by 2.7% on a box basis and by 9.3% on USD basis, resulting in USD 7.7 billion in 2019. The total pharmaceutical market reached TL 31,4 billion, with a growth of 31.4%.

 

* The title of the company IMS HEALTH TIBBİ İSTATİSTİK TİCARET VE MÜŞAVİRLİK LTD. ŞTİ. was changed to IQVIA TIBBİ İSTATİSTİK TİCARET VE MÜŞAVİRLİK LTD. ŞTİ., as of 13.04.2019.

** “Surplus Goods” are included in the value in units but not included in the value in TL based on the IQVIA calculation method change.

 

Source: IQVIA Free + Tender Data View